Pharmacologic Treatment of Myocardial Ischemia Detected by Intracoronary ECG

NCT03383393 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-12-26

No results posted yet for this study

Summary

After PCI searching for target lesion ischemia with intracoronary ECG will be performed and if found it will be treated pharmacologically

Conditions

  • Coronary Ischemia

Interventions

DRUG

Intracoronary bolus of adenosine (adenocor), Integrilin (eptifibatide) or nitroglyzerin (nitronal)

intracoronary drugs

Sponsors & Collaborators

  • Alexandrovska University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-03
Primary Completion
2019-12-05
Completion
2019-12-05

Countries

  • Bulgaria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03383393 on ClinicalTrials.gov